Type 2 Diabetes Trial, Recruiting NCT06750497 Sponsor: Wageningen University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06750497
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female, with or without a diagnosis of type 2 diabetes
  • People who manage their blood sugar through lifestyle changes, metformin, gliclazide, or a combination of these
  • People who are between 18 and 80 years old at the time of signing the consent form
  • People with a BMI between 18.5 and 35 kg/m² (confirm with trial site)

Who may not be able to join:

  • People who have type 1 diabetes or a diabetes caused by a genetic condition
  • People who have been diagnosed with any heart or cardiovascular disease, or who have high blood pressure (160/100 mmHg or above)
  • People who regularly take any prescribed or over-the-counter medications (other than contraceptives) that affect how muscles process energy — for example, antidepressants known as SSRIs (confirm with trial site)
  • People who follow a low-carbohydrate diet
  • People who currently smoke or chew tobacco
  • People who have been diagnosed with anaemia (low red blood cells or iron)
  • People who regularly use protein powders or amino acid supplements more than 3 times per week
  • People who are currently doing a structured, progressive weight or resistance training program more than 3 times per week
  • People who have a personal or family history of blood clots (thrombosis)
  • People who have a history of movement disorders or inherited conditions affecting muscles or fat metabolism
  • People with a history of kidney disease
  • People with a history of liver disease
  • People who are currently pregnant or breastfeeding
  • People with a history of drug or alcohol misuse in the past two years
  • People who experience claustrophobia
  • People who are unable to give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 317 480 100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wageningen University
Registry
ClinicalTrials.gov
Start date
21 November 2024
Est. completion
30 April 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change in forearm muscle glucose uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov